Merck KGaA 27. Apr. 2026 Merck KGaA: Small Breakout In 2026, Followed By Normalization (OTCMKTS:MKGAF) - Seeking Alpha
FierceBiotech 22. Apr. 2026 Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
FierceBiotech 21. Apr. 2026 In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
BioPharma Dive 20. Apr. 2026 AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle
FierceBiotech 17. Apr. 2026 Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans
Endpoints News 8. Apr. 2026 Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application
Endpoints News 7. Apr. 2026 Terns sold to Merck for 13% lower than pharma's initial offer because of clinical data
Merck KGaA 1. Apr. 2026 Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business - Merck Group
FierceBiotech 25. März 2026 Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
Endpoints News 25. März 2026 Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix